Highlight text to provide feedback
| Disease found: | Acute Myeloid Leukemia |
| Current as of: | October 8, 2024 |
| Disease Overview: | Incomplete maturation of blood cells and reduced production of other normal hematopoietic stem cells. [more info] |
| Signs and Symptoms: | Weakness, fatigue, dyspnea, recurrent infections, and prolonged bleeding. [more info] |
| Diagnosis: | Identification of characteristic symptoms, a detailed patient history, a thorough clinical evaluation, and a variety of specialized tests. [more info] |
| Treatment: | The initial treatment is induction therapy, however treatments vary. [more info] |
| Clinical Management: | Therapeutic management may require the coordinated efforts of a team of medical professionals. [more info] |
| Referral: | ~ 200 US-based physicans [more info]. Referral to Medical Genetics Department, if available. Initial virtual care is also available through organizations like TeleRare Health. |
| Clinical Trials: | ~ 1,200 trials [more info] |